Bridgeway Capital Management, LLC Homology Medicines, Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.84 - $1.43 $25,200 - $42,900	30,000 Added 19.34%	185,100 $216,000
Q2 2023 Aug 14, 2023	SELL	$0.83 - $1.12 $62,250 - $84,000	-75,000 Reduced 32.59%	155,100 $136,000
Q1 2023 May 15, 2023	BUY	$0.91 - $1.69 $5,096 - $9,464	5,600 Added 2.49%	230,100 $237,000
Q4 2022 Feb 14, 2023	BUY	$1.09 - $2.04 $27,250 - $51,000	25,000 Added 12.53%	224,500 $282,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $155,000 - $301,000	100,000 Added 100.5%	199,500 $321,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $69,500 - $156,000	-50,000 Reduced 33.44%	99,500 $196,000
Q1 2022 May 16, 2022	BUY	$2.6 - $4.17 $388,700 - $623,415	149,500 New	149,500 $454,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.